ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes

September 10, 1999

Argentine Human Rights Violations Continue, But Some Improvement Seen

October 20, 1978

Study Finds Short Term Tests Predict Carcinogenicity

April 25, 1980

Congress Nearing Final Action On Appropriations, But Potential GRH Cuts Leaves Outlook Unclear

September 12, 1986

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013

Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility

February 1, 1980